Purpose: To determine whether the Putterman-Gladstone tube is a safe and effective lacrimal bypass tube in conjunctival dacryocystorhinostomy surgery.
Methods: The authors retrospectively reviewed the charts of patients who underwent conjunctival dacryocystorhinostomy with the Putterman-Gladstone tube between January 1994 and December 2010. Clinical data reviewed included demographics, ocular and surgical history, epiphora symptoms, complications, and repeat surgery information. Success was defined as resolution of epiphora or greatly improved symptoms of epiphora at last follow up.
Results: Twenty-five patients and 29 eyes of patients undergoing conjunctival dacryocystorhinostomy surgery with Putterman-Gladstone were identified. Mean follow up was 35.61 months. Complications of surgery included occlusion in 10.3%, malposition in 17.2%, discomfort in 24.1%, and extrusion in 37.9%. Median time to extrusion was 8 months. Repeat operative intervention was required in 41.4% of patients. Twenty-five of 29 (86.2%) patients had complete resolution of epiphora or only mild residual epiphora at last follow up.
Conclusion: This retrospective chart review demonstrates the efficacy and safety of the Putterman-Gladstone tube in conjunctival dacryocystorhinostomy surgery.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/IOP.0b013e31826115fe | DOI Listing |
Clin Exp Optom
December 2024
Department of Ophthalmology, Erciyes University, Kayseri, Turkey.
Clinical Relevance: Endonasal dacryocystorhinostomy (EN-DCR) is one of the preferred interventions for occlusion of the nasolacrimal drainage system. Understanding the bulbar conjunctival changes that occur after EN-DCR surgery will provide better insight into the effect of this procedure on visual quality and patient comfort.
Background: This study aimed to evaluate visual quality and bulbar conjunctival cytologic changes using in vivo confocal microscopy and corneal topography in patients with epiphora resulting from nasolacrimal duct obstruction after EN-DCR.
Int Ophthalmol
December 2024
Department of Ophthalmology, Division of Oculoplastic and Lacrimal Surgery Unit, Erciyes University Medical Faculty, Kayseri, Türkiye.
Purpose: We evaluated the surgical outcomes and management of complications associated with the minimally invasive conjunctivodacryocystorhinostomy using the StopLoss Jones (SLJT) tube of proximal lacrimal canal obstruction.
Methods: The study retrospectively included 22 eyes of 15 patients who underwent SLJT for proximal canalicular obstruction. Age, gender, follow-up duration, etiology of canalicular obstruction, previous surgery, tube size, complications, and the need for additional surgical intervention were assessed.
Am J Ophthalmol Case Rep
December 2024
Department of Ophthalmology, Saitama Medical University, 38 Morohongo, Moroyama, Saitama, 350-0495, Japan.
Purpose: To report a case of lacrimal drainage pathway disease-associated keratopathy (LDAK) with endophthalmitis.
Observations: An 80-year-old man with diabetic retinopathy and nephropathy was referred to our hospital with endophthalmitis of the left eye. Slit-lamp examination revealed slight eye discharge, peripheral corneal ulcers, diffuse hyperemia of the conjunctiva, iris synechia, and a large amount of fibrin in the anterior chamber of the left eye.
Heliyon
October 2024
Department of Ophthalmology, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, South Korea.
Indian J Ophthalmol
November 2024
Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin, China.
Purpose: To investigate the effects of hydroxybutyl chitosan (HBCS) with and without 5-fluorouracil (5-FU) during endoscopic endonasal dacryocystorhinostomy (Endo-DCR). In addition, the present study observed the impact of HBCS and 5-FU on the functions of the nasal mucosal cell population in vivo .
Methods: Patients were randomized into HBCS (group A), HBCS combined with 5-FU (group B), and gelatin sponge control group (group C).
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!